137 related articles for article (PubMed ID: 37094450)
1. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT
Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450
[TBL] [Abstract][Full Text] [Related]
2. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.
Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F
J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
[TBL] [Abstract][Full Text] [Related]
4. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
[TBL] [Abstract][Full Text] [Related]
5. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
Smith KE; Boules M; Williams K; Richelson E
Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
[TBL] [Abstract][Full Text] [Related]
6. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
[TBL] [Abstract][Full Text] [Related]
8. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.
Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S
J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.
Ferraro L; Beggiato S; Borroto-Escuela DO; Ravani L; O'Connor WT; Tomasini MC; Borelli AC; Agnati LF; Antonelli T; Tanganelli S; Fuxe K
Curr Protein Pept Sci; 2014; 15(7):681-90. PubMed ID: 25175457
[TBL] [Abstract][Full Text] [Related]
10. Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.
Oliveros A; Heckman MG; Del Pilar Corena-McLeod M; Williams K; Boules M; Richelson E
J Exp Biol; 2010 Dec; 213(Pt 24):4232-9. PubMed ID: 21113004
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P
Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin NTS
Steele FF; Whitehouse SC; Aday JS; Prus AJ
Brain Res; 2017 Mar; 1658():31-35. PubMed ID: 28089664
[TBL] [Abstract][Full Text] [Related]
13. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
[TBL] [Abstract][Full Text] [Related]
14. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.
Perron A; Sharif N; Sarret P; Stroh T; Beaudet A
Biochem Biophys Res Commun; 2007 Feb; 353(3):582-90. PubMed ID: 17188644
[TBL] [Abstract][Full Text] [Related]
15. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
[TBL] [Abstract][Full Text] [Related]
16. Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.
Li Z; Liang Y; Boules M; Gordillo A; Richelson E
Neuropharmacology; 2010 Jun; 58(7):1174-8. PubMed ID: 20193696
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin analogs by fluoroglycosylation at N
Schindler L; Wohlfahrt K; Gluhacevic von Krüchten L; Prante O; Keller M; Maschauer S
Sci Rep; 2022 Sep; 12(1):15028. PubMed ID: 36056076
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
[TBL] [Abstract][Full Text] [Related]
19. Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.
Held C; Plomer M; Hübner H; Meltretter J; Pischetsrieder M; Gmeiner P
ChemMedChem; 2013 Jan; 8(1):75-81. PubMed ID: 23097347
[TBL] [Abstract][Full Text] [Related]
20. Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.
Lee MR; Hinton DJ; Unal SS; Richelson E; Choi DS
Alcohol Clin Exp Res; 2011 Jan; 35(1):99-107. PubMed ID: 21039631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
